Biotech

Advaxis Inc (NASDAQ:ADXS) shares rose 1.96% to $9.38 on Monday and were unchanged in after-hours trading. Share prices have been trading in a 52-week range of $5.21 to $16.30. The company has a market cap of $385.81 million at 40.15 million shares outstanding. Advaxis Inc is a clinical-stage biotechnology company that...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Sino Agro Food Inc. (OTCMKTS:SIAF) reported that Forsakringsaktiebolaget Avanza Pension has picked up 2,778,385 of common stock as of 2017-02-06. The acquisition brings the aggregate amount owned by Forsakringsaktiebolaget Avanza Pension to a total of...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Pacific Biosciences of California Inc. (NASDAQ:PACB) reported that Feinberg Larry N. has picked up 5,516,894 of common stock as of 2017-02-06. The acquisition brings the aggregate amount owned by Feinberg Larry N. to a total...

VBI Vaccines, Inc. - Ordinary Shares (NASDAQ:VBIV) has had a strong start to 2017, currently trading for a circa 22% premium on it's December close price. For this young biotechnology company, however, things are really only just getting started. With a diverse pipeline of development stage assets, and a...

Easton Pharmaceuticals Inc (OTCMKTS:EAPH) shares were up 19.21% to $0.0391 and flat in after-hours trading. Share prices have been trading in a 52-week range of $0.00 to $0.04. The company has a market cap of $39.61 million at 923.73  million shares outstanding. Easton Pharmaceuticals Inc is a development-stage company engaged in...